We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant
RVMDW

24 hedge funds and large institutions have $1.71M invested in Revolution Medicines Inc Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

64% more capital invested

Capital invested by funds: $1.04M → $1.71M (+$669K)

1.72% more ownership

Funds ownership: 2.83% → 4.56% (+1.7%)

4% less funds holding

Funds holding: 25 → 24 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
4
Calls
$12.3M
Puts
–
Net Calls
+$12.3M
Net Calls Change
-$10M

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$767K
2
AC
Aristeia Capital
Connecticut
+$94.4K
3
DCM
Driehaus Capital Management
Illinois
+$39.9K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$31.8K
5
CL
CSS LLC
Illinois
+$2.84K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$3.31K
2
Walleye Capital
Walleye Capital
New York
-$863
3
CA
CoreCap Advisors
Michigan
-$14
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$467K +$767K +2,595,245 New
BFM
2
Boothbay Fund Management
New York
$356K – – –
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$235K +$31.8K +107,456 +8%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$97K – – –
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$90K – – –
SCM
6
Soros Capital Management
New York
$65.7K – – –
Walleye Capital
7
Walleye Capital
New York
$63K -$863 -2,919 -0.8%
AC
8
Aristeia Capital
Connecticut
$54.3K +$94.4K +319,131 New
PA
9
Perceptive Advisors
New York
$45K – – –
CL
10
CSS LLC
Illinois
$42.5K +$2.84K +9,607 +58%
BL
11
Bleichroeder LP
New York
$36K – – –
SC
12
Sculptor Capital
New York
$30.3K – – –
DKCM
13
Davidson Kempner Capital Management
New York
$27K – – –
DCM
14
Driehaus Capital Management
Illinois
$20.3K +$39.9K +135,000 New
FCM
15
Farallon Capital Management
California
$19.4K – – –
MF
16
Magnetar Financial
Illinois
$19.3K – – –
DIM
17
DLK Investment Management
California
$13.9K – – –
WAM
18
Wolverine Asset Management
Illinois
$12.7K – – –
WAM
19
Weiss Asset Management
Massachusetts
$11.9K – – –
TD Asset Management
20
TD Asset Management
Ontario, Canada
$6.57K – – –
UBS Group
21
UBS Group
Switzerland
$485 +$788 +2,664 +9,514%
TWC
22
TD Waterhouse Canada
Ontario, Canada
$72 – – –
CAC
23
Cowen and Company
New York
– -$27.4K -195,600 Closed
Citadel Advisors
24
Citadel Advisors
Florida
– -$3.31K -23,660 Closed
CA
25
CoreCap Advisors
Michigan
– -$14 -100 Closed
1
2

RVMDW Hedge Fund Activity: Q4 2024 in Review

24 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q4 2024, worth a combined $1.71M — up 64% from $1.04M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RVMDW and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was LMR Partners, opening a new position worth an estimated $767K. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.31K sold.

  • 24 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q4 2024, down from 25 in Q3 2024.
  • Funds reported $1.71M of Revolution Medicines Inc Warrant stock for Q4 2024, up 64% quarter-over-quarter.
  • 3 funds opened new Revolution Medicines Inc Warrant positions in Q4 2024 and 4 closed out, a net change of -1 holder.
  • The largest Revolution Medicines Inc Warrant buyer in Q4 2024 was LMR Partners, an estimated $767K added.
  • The largest Revolution Medicines Inc Warrant seller in Q4 2024 was Citadel Advisors, an estimated $3.31K sold.

Based on aggregated 13F filings for Q4 2024.